Childhood cancers trials in China

In China 609 Also abroad 2483

609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in China
Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients
Where
Shanghai
Age
12 years to 70 years
People
23
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07142863
Phase 2/3Taking people
Newly-diagnosed Pediatric T-cell ALL Protocol
Where
Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hefei, Jinan, Nanchang, Nanjin, Nanning, Qingdao, Shanghai, Shenzhen, Suzhou, Tianjin, Wuhan, Xi’an
Age
1 month to 18 years
People
610 worldwide
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06855810
Phase 2/3Taking people
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Where
Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hefei, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shenzhen, Suzhou, Tianjin, Wuhan, Xi’an
Age
1 year to 18 years
People
3,000 worldwide
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06882057
No phaseTaking people
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
Where
Beijing
People
30
Run by
Luo Yaping
See details and how to joinNCT07138716
Phase 2Taking people
Pola-ZR2P in Previously Untreated DLBCL
Where
Beijing
Age
14 years and over
People
80
Run by
Navy General Hospital, Beijing
See details and how to joinNCT06664411
Phase 2Enrolling by invitation
Sonodynamic-Chemoradiotherapy Integration in Glioblastoma
Where
Zhengzhou
Age
Up to 75 years
People
230
Run by
Yingjuan Zheng
See details and how to joinNCT07130149
No phaseTaking people
A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data
Where
Changsha
People
100,000
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT07126821
Phase 4Taking people
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Where
Beijing, Fuzhou, Hangzhou, Hohhot, Shanghai, Shanxi, Wuhan, Zhengzhou
People
800
Run by
Fudan University
See details and how to joinNCT06195228
Phase 1/2Taking people
A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
Where
Chongqing, Guangzhou, Hefei, Nanchang, Nanjing, Tianjin, Wuhan, Xuzhou
Age
3 years to 18 years
People
47
Run by
Juventas Cell Therapy Ltd.
See details and how to joinNCT05667506
Phase 1/2Not yet taking people in China
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation
Where
Zhengzhou
Age
14 years to 65 years
People
38
Run by
Zhengzhou University
See details and how to joinNCT07117305
No phaseTaking people
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
Where
Hangzhou
Age
Up to 18 years
People
200
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06852807
Phase 2Taking people
Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study
Where
Taiyuan
Age
14 years to 65 years
People
50
Run by
Shanxi Bethune Hospital
See details and how to joinNCT07108530
Phase 2Taking people
Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage
Where
Tianjin
Age
14 years and over
People
50
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04440267
No phaseTaking people
Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer
Where
Guangzhou
Age
6 years to 18 years
People
124
Run by
Wei XIA, PhD
See details and how to joinNCT05922553
Phase 1/2Taking people
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
Where
Beijing
Age
2 years to 90 years
People
75
Run by
Essen Biotech
See details and how to joinNCT06213636
Phase 2Taking people
Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer
Where
Shanghai
People
119
Run by
Fudan University
See details and how to joinNCT06856187
Phase 2Taking people
Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia
Where
Hangzhou
Age
14 years to 65 years
People
31
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07105579
No phaseEnrolling by invitation
A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics
Where
Beijing
People
250
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07107815
Phase 2Taking people
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
Where
Suzhou
Age
12 years and over
People
60
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07101497
Phase 2Taking people
Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Where
Tianjin
Age
14 years to 60 years
People
100
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT05660473
No phaseTaking people
AI-Driven Cancer Diagnosis and Prediction With EHR
Where
Chengdu, Guangzhou, Wenzhou
Age
0 years to 90 years
People
1,000,000
Run by
The Eye Hospital of Wenzhou Medical University
See details and how to joinNCT06791473
Phase 2Taking people
Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors
Where
Beijing
Age
16 years and over
People
30
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06553365
Early phase 1Taking people
Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
Where
Chengdu
Age
12 months and over
People
10
Run by
Sichuan University
See details and how to joinNCT07067346
Early phase 1Not yet taking people in China
GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.
Where
Beijing
Age
6 years to 12 years
People
10
Run by
Chinese PLA General Hospital
See details and how to joinNCT07090538
Phase 2Not yet taking people in China
Efficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML
Where
Shanghai
Age
14 years to 70 years
People
44
Run by
Ruijin Hospital
See details and how to joinNCT07091006